ArticleACS medicinal chemistry letters2025

A Conjugate of an EGFR-Binding Peptide and Doxorubicin Shows Selective Toxicity to Triple-Negative Breast Cancer Cells.

Phi-Phung Than et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.